• 其他栏目

    崔华

    • 教授 博士生导师 硕士生导师
    • 教师英文名称:Hua Cui
    • 电子邮箱:
    • 办公地点:环境资源楼-339
    • 联系方式:0551-3600730
    • 学位:博士
    • 2006当选:国家杰出青年科学基金获得者

    访问量:

    开通时间:..

    最后更新时间:..

    Three-Biomarker Joint Strategy for Early and Accurate Diagnosis of Acute Myocardial Infarction via a Multiplex Electrochemiluminescence Immunoarray Coupled with Robust Machine Learning

    点击次数:

    DOI码:10.1021/cbmi.3c00035

    发表刊物:Chem. Biomed. Imaging

    摘要:Acute myocardial infarction (AMI) represents a leading cause of death globally. Key to AMI recovery is timely diagnosis and initiation of treatment, ideally within 3 h of symptom onset. Cardiac troponin T (cTnT) is the gold standard yet a low cTnT result cannot rule out AMI at early times. Here, we develop a three-biomarker joint strategy for early and accurate diagnosis of AMI via an electrochemiluminescence (ECL) immunoarray coupled with robust machine learning. The ECL immunoarray is based on an array microchip with a single-electrode and chemiluminescent immuno-Gold (ciGold) nanoassemblies. The ciGold immunoarray was obtained by successively assembling nanocomposites of Cu2+/cysteine complexes and N-(aminobutyl)-N-(ethylisoluminol) bifunctionalized gold nanoparticles combined with chitosan and antibody conjugated gold nanoparticles on the surface of a microchip. Three biomarkers, including cardiac troponin I, heart type fatty acid binding protein, and copeptin, were simultaneously detected in 260 serum samples from patients presenting with chest pain by an innovative multiplexed ECL immunoarray, and classified via the three-biomarker joint assessment model using support vector machines. The model achieved perfect discrimination (100% sensitivity and specificity) for AMI vs non-AMI patients, substantially higher than cTnT alone. Within 12 h of symptom onset, high-sensitivity cardiac troponin T (hs-cTnT) misclassified >20% of patients, while the joint biomarker assessment model retained perfect accuracy. As the time between symptom onset and testing became shorter, the degree to which the joint assessment model outperformed hs-cTnT increased. The proposed three-biomarker joint strategy is obviously superior to hs-cTnT for early and accurate diagnosis of AMI, hopefully reducing AMI mortality and saving limited medical resources.

    合写作者:马瑶,Mohammad A. Haghighatbin,卞智萍,杨迪,张婼娴,聂威,舒江南,王珏,杜德鑫

    第一作者:郭明全

    论文类型:期刊论文

    通讯作者:王连生,Zachary J. Smith,崔华

    学科门类:理学

    文献类型:J

    卷号:1

    期号:2

    页面范围:179–185

    是否译文:

    发表时间:2023-06-28

    收录刊物:SCI

    发布期刊链接:https://pubs.acs.org/doi/full/10.1021/cbmi.3c00035